Artificial Organs (LEBAO) , the Clinic for Pediatric Pneumology, Allergology and Neonatology , and the Institute of Quantum Optics (Leibniz University) at the NIFE are at the forefront in this research area. By [...] become aware of scientific education and carrier opportunities in regenerative medicine on a trans-institutional and trans-Atlantic level. Besides the scientific collaboration, the program promotes MHHs int

laboratory animals - this characterises the work of Professor Dr. André Bleich, Director of the Institute for Laboratory Animal Science and the Central Animal Laboratory of the Hannover Medical School (MHH) [...] animal protection," explains Michaela Dämmrich. Fifteen working groups from seven Lower Saxony institutions are working in the R2N consortium, which was launched in 2017. The aim of the project is to develop

caused by viruses, fungi and bacteria. A research team led by Dr Anna Christina Dragon from the Institute of Transfusion Medicine and Transplant Engineering at Hannover Medical School (MHH) is now developing [...] donated organ after transplantation," emphasises Professor Dr Britta Eiz-Vesper, immunologist at the Institute and expert in immunotherapies. Therapeutic potential not only for transplant medicine In preliminary [...] would also help to improve the existing problem of living kidney donations in Germany," emphasises Institute Director Professor Dr Rainer Blasczyk. In Germany, only first and second-degree relatives, spouses

cooperative projects between physicians in a region, municipal administrations or the county and the Institute of General Medicine and Palliative Medicine at the MHH. This project also aims to give future doctors [...] Heidekreis as well as in Hameln, Pyrmont, Schaumburg. A total of 15 places are available per round. The Institute of General Medicine and Palliative Medicine at the MHH is responsible for supervising the teaching

sciences. The "Who's Who" of science also provides information about the countries and research institutions in which the scientific elite work. 336 of these experts work in Germany, putting it in fourth [...] pulmonary hypertension, i.e. pulmonary hypertension. Professor Dr Thomas Thum is Director of the MHH Institute for Molecular and Translational Therapy Strategies. For many years, the cardiologist and bioscientist

Hannover Medical School (MHH) is participating as a data integration centre via the Peter L. Reichertz Institute (PLRI). The Department of Paediatric Pneumology, Allergology and Neonatology at the MHH Children's [...] funding of more than one million euros. Participants are not specifically selected "With our partner institutions, we want to bring together data not only from the hospital information systems but also from

Susceptibility) cluster of excellence with significant participation by the Peter L. Reichertz Institute for Medical Informatics (PLRI) of the MHH and the TU Braunschweig. The first 18 students have now [...] to start the study programme together with you," said Prof. Dr. Thomas Schulz, head of the MHH Institute of Virology and spokesperson of the RESIST Cluster of Excellence, at the opening ceremony on 7 October

Bergmann, Institute of Human Genetics and scientist at the Comprehensive Cancer Center (CCC) of the Hannover Medical School (MHH) takes over the leadership of the EU project, together with the Institute for

Haematology, Haemostaseology, Oncology and Stem Cell Transplantation and Dr. Ivan Odak from the Institute of Immunology at the Hannover Medical School (MHH) has examined the blood of more than 240 healthy [...] the Department of Haematology, Haemostaseology, Oncology and Stem Cell Transplantation and the Institute of Immunology as well as the Department of Transfusion Medicine and Tissue Engineering and was funded

Paediatric Pneumology, Allergology and Neonatology. Fundamental work was also performed at the MHH Institute for Experimental Haematology. His laboratory is part of the MHH REBIRTH Research Centre for Tra [...] Cluster of Excellence RESIST (Resolving Infection Susceptibility), more than 50 teams from six institutions led by the MHH are investigating why people are differently susceptible to infections. Their goal